Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImpax Asset Management Regulatory News (IPX)

Share Price Information for Impax Asset Management (IPX)

Share Price is delayed by 15 minutes
Get Live Data
101.40    2.90 (2.94%)
Bid:
99.20
Ask:
101.40
Spread: 2.20 (2.218%)
Market Cap: £123.20m
IPX Live PriceLast checked at - London Stock Exchange

Intraday Impax Asset Management Share Chart

Additional Listing

23 Sep 2008 15:54

RNS Number : 1161E
Impax Group PLC
23 September 2008
 



Impax Group plc 

On 18th September 2008, Impax Group plc (the "Company") received a subscription notice from Sanne Trust Company Limited, the trustee of the Impax Group Employee Benefit Trust 2005 (the "IGEBT") for 6,083,333 new Ordinary Shares of 1p ("Ordinary Shares") as part of the Company's employee incentive arrangements as approved at the Company's EGM on 31 January 2008. The potential beneficiaries of the IGEBT include the executive directors and employees of the Company and their families.

Accordingly the Company has allotted 6,083,333 Ordinary Shares, subject to admission of the shares to trading on the AIM of the London Stock Exchange.

Application has been made to the London Stock Exchange for admission of the 6,083,333 Ordinary Shares to AIM. It is expected that admission will become effective and trading will commence on 24 September 2008. Following allotment the Company will have 115,582,431 Ordinary Shares in issue. 

IGEBT will be interested in 19.4% of the enlarged share capital of the Company.

23rd September 2008

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
LISSEDFLDSASEIU
Date   Source Headline
31st May 20237:00 amRNSHalf-year Report
26th May 20233:10 pmRNSInvestment Advisory Agreement
26th May 20237:00 amRNSHolding(s) in Company
23rd May 20237:00 amRNSInvestor Presentation of Interim Results
15th May 20232:25 pmRNSHolding(s) in Company
9th May 20237:00 amRNSNotice of Results
11th Apr 20237:00 amRNSQ2 AUM Update
16th Mar 20231:57 pmRNSDirectorate Changes
16th Mar 20231:56 pmRNSResult of AGM
15th Mar 20238:43 amRNSHolding(s) in Company
9th Jan 20237:00 amRNSQ1 AUM update
20th Dec 20223:46 pmRNSDirector/PDMR Shareholding
20th Dec 20223:33 pmRNSHolding(s) in Company
16th Dec 20224:46 pmRNSNotice of AGM
13th Dec 20223:02 pmRNSHolding(s) in Company
1st Dec 20225:06 pmRNSPublication of Annual Financial Report
1st Dec 20227:00 amRNSDirector/PDMR Shareholding
30th Nov 20227:00 amRNSFinal Results
25th Nov 20227:00 amRNSinvestor Presentation of Full Year Results
23rd Nov 20227:00 amRNSNotice of results
21st Nov 20225:05 pmRNSHolding(s) in Company
7th Oct 20227:00 amRNSAUM update
3rd Oct 20228:22 amRNSHolding(s) in Company
13th Sep 202210:49 amRNSHolding(s) in Company
9th Sep 20221:32 pmRNSHolding(s) in Company
2nd Sep 20223:34 pmRNSHolding(s) in Company
12th Aug 20229:37 amRNSDirector/PDMR Shareholding
21st Jul 20225:38 pmRNSHolding(s) in Company
7th Jul 20227:00 amRNSAUM update
6th Jul 20221:50 pmRNSDirector/PDMR and PCA Shareholding
29th Jun 20227:00 amRNSDirector/PDMR Shareholding
28th Jun 20227:00 amRNSBoard Appointment
16th Jun 20224:37 pmRNSDirector/PDMR and PCA Shareholding
14th Jun 20227:00 amRNSHolding(s) in Company
7th Jun 20224:36 pmRNSHolding(s) in Company
1st Jun 20227:00 amRNSInterim results to 31 March 2022
12th May 20228:16 amRNSHolding(s) in Company
12th May 20227:00 amRNSInvestor Presentation of Interim Results
6th May 20227:00 amRNSDate of Interim Results
26th Apr 20223:37 pmRNSHolding(s) in Company
20th Apr 20222:11 pmRNSDirector/PDMR Shareholding
7th Apr 20227:00 amRNSAUM update
30th Mar 20222:14 pmRNSDirector/PDMR Shareholding
29th Mar 20226:10 pmRNSResult of AGM
4th Mar 20222:30 pmRNSDirector/PDMR and PCA Shareholding
25th Feb 20227:00 amRNSAIM Rule 17 Schedule Two (g) Update
14th Feb 20221:24 pmRNSDistribution agreement
10th Jan 20227:00 amRNSAUM update
20th Dec 20216:04 pmRNSNotice of Annual General Meeting ("AGM")
20th Dec 20217:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.